HCPCS Codes Similar to C9285

HCPCS Codes Similar to “C9285” Code.
Lidocaine 70 mg/tetracaine 70 mg, per patch

J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg Code added date: 20040101 Code effective date: 20241001 TXT \| PDF \| XML \| JSON	J2002 Injection, lidocaine hcl in 5% dextrose, 1 mg Code added date: 20241001 Code effective date: 20250101 TXT \| PDF \| XML \| JSON
J2003 Injection, lidocaine hydrochloride, 1 mg Code added date: 20241001 Code effective date: 20241001 TXT \| PDF \| XML \| JSON	J2004 Injection, lidocaine hcl with epinephrine, 1 mg Code added date: 20241001 Code effective date: 20241001 TXT \| PDF \| XML \| JSON
J7335 Capsaicin 8% patch, per 10 square centimeters Code added date: 20110101 Code effective date: 20150101 TXT \| PDF \| XML \| JSON	J7336 Capsaicin 8% patch, per square centimeter Code added date: 20150101 Code effective date: 20150101 TXT \| PDF \| XML \| JSON
Q4224 Human health factor 10 amniotic patch (hhf10-p), per square centimeter Code added date: 20220401 Code effective date: 20220401 TXT \| PDF \| XML \| JSON	Q4247 Amniotext patch, per square centimeter Code added date: 20200701 Code effective date: 20200701 TXT \| PDF \| XML \| JSON
G9666 Patient's highest fasting or direct ldl-c laboratory test result in the measurement period or two years prior to the beginning of the measurement period is 70-189 mg/dl Code added date: 20160101 Code effective date: 20220101 TXT \| PDF \| XML \| JSON	G9667 Documentation of medical reason(s) for not currently being a statin therapy user or receive an order (prescription) for statin therapy (e.g., patient with adverse effect, allergy or intolerance to statin medication therapy, patients who have an active diagnosis of pregnancy or who are breastfeeding, patients who are receiving palliative care, patients with active liver disease or hepatic disease or insufficiency, patients with end stage renal disease (esrd), and patients with diabetes who have a fasting or direct ldl-c laboratory test result < 70 mg/dl and are not taking statin therapy) Code added date: 20160101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON
G9668 Documentation of medical reason (s) for not currently being a statin therapy user or receive an order (prescription) for statin therapy (e.g., patient with adverse effect, allergy or intolerance to statin medication therapy, patients who have an active diagnosis of pregnancy or who are breastfeeding, patients who are receiving palliative care, patients with active liver disease or hepatic disease or insufficiency, patients with end stage renal disease (esrd), and patients with diabetes who have a fasting or direct ldl-c laboratory test result < 70 mg/dl and are not taking statin therapy) Code added date: 20160101 Code effective date: 20160101 TXT \| PDF \| XML \| JSON	G9676 Patients aged 40 to 75 years at the beginning of the measurement period with type 1 or type 2 diabetes and with an ldl-c result of 70-189 mg/dl recorded as the highest fasting or direct laboratory test result in the measurement year or during the two years prior to the beginning of the measurement period Code added date: 20160101 Code effective date: 20160101 TXT \| PDF \| XML \| JSON
G9783 Documentation of patients with diabetes who have a most recent fasting or direct ldl- c laboratory test result < 70 mg/dl and are not taking statin therapy Code added date: 20170101 Code effective date: 20220101 TXT \| PDF \| XML \| JSON	A2014 Omeza collagen matrix, per 100 mg Code added date: 20221001 Code effective date: 20221001 TXT \| PDF \| XML \| JSON